Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Frederic Kerrest - aVenture Research

Frederic Kerrest

AddedFeb 14, 2024

UpdatedOct 12, 2026

Frederic Kerrest

Frederic Kerrest

Founder, The Operator Network

Frederic Kerrest's Career

The Operator Network

Frederic Kerrest's Co-Investors

Ryan CarlsonCo-invested · Doppel Series A · 5 deals

Elad GilCo-invested · Socket Series A · 4 deals

Gokul RajaramCo-invested · Doppel Series A · 3 deals

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Frederic Kerrest's Investments

31 investments since 2017

29 operating · 2 acquired

Investments view

Group by

2024

1

Doppel
Series A · January 2024$18.8M
Series A · January 2024

2023

3

Verve
Series B · December 2023$20M
Series B · December 2023
Socket
Series A · follow-on · August 2023$20M
Series A · follow-on · August 2023
Granica
Series A · June 2023$45M
Series A · June 2023

2022

10

SecurityPal
Series A · September 2022$21M
Series A · September 2022
Trek Health
Seed · September 2022$2.7M
Seed · September 2022
AirWorks
Series Unknown · July 2022$5M
Series Unknown · July 2022
Trinsic
Seed · June 2022$8.5M
Seed · June 2022
Socket
Seed · May 2022$4.6M
Seed · May 2022

2021

7

Casa
Series A · December 2021$21M
Series A · December 2021
Vowel
Series A · September 2021$13.5M
Series A · September 2021
Workstream
Series B · August 2021$48M
Series B · August 2021
Airbase
Series B · August 2021$60M
Series B · August 2021
Trustworthy
Seed · June 2021
Seed · June 2021

2020

5

Modern Health
Series C · December 2020$51M
Series C · December 2020
Onc.AI
Seed · December 2020$6M
Seed · December 2020
Stensul
Series B · November 2020$16M
Series B · November 2020
Swantide
Seed · July 2020
Seed · July 2020
Front
Series C · January 2020$59M
Series C · January 2020

2019

4

Xokind
Pre-Seed · December 2019$3.6M
Pre-Seed · December 2019
Nightfall
Series A · November 2019$20.3M
Series A · November 2019
Securiti
Series A · August 2019$31M
Series A · August 2019
Bubble
Seed · June 2019$6.3M
Seed · June 2019

2017

1

Lively, Inc.
Seed · September 2017$4.2M
Seed · September 2017

Investment Firm

San Francisco, CA, US

Founder

Okta Ventures

Investment FirmSan Jose, CA, US

Co-Founder

Okta

Public$1.2BSan Francisco, CA, US

Co-Founder

Board Member· Board

Herophilus

Seed$16MSan Francisco, CA, US

Board Member· Board

System1 Biosciences

Series A$25MSan Francisco, CA, US

Co-Founder

Board Member· Board

Kevin HartzCo-invested · Socket Series A · 3 deals

Guillermo RauchCo-invested · Socket Series A · 2 deals

Eric YuanCo-invested · Workstream Series B · 2 deals

Ramsey HomsanyCo-invested · Doppel Series A · 2 deals

Nat FriedmanCo-invested · Socket Series A · 2 deals

People Similar to Frederic Kerrest

Shellye ArchambeauBoard Member · Verizon

Kerri-Lynn Primmer MorrisBoard Member · Heru

John FrantzisBoard Member · Heru

Similar to The Operator Network

Operator CollectiveSan Francisco, CA, USest. 2019Operator CollectiveSan Francisco, CA, US · est. 2019

Operator Collective: A venture fund uniting 200+ top tech executives to invest in next-gen enterprise tech.

Investment Firm144

Coalition OperatorsSan Francisco, CA, USest. 2020Coalition OperatorsSan Francisco, CA, US · est. 2020

San Francisco-based Coalition Operators provides financial services and invests in early-stage startups.

Investment Firm5

Operator PartnersNew York City, NY, USest. 2020Operator PartnersNew York City, NY, US · est. 2020

Operator Venture: A self-funded tech investment firm, partnering with and funding early-stage startups.

Investment Firm7

Operative CapitalSausalito, CA, USest. 2014Operative CapitalSausalito, CA, US · est. 2014

Operative Capital: Early-stage investor in disruptive fintech start-ups, providing hands-on support and mentoring.

Investment Firm6

Similar to Okta Ventures

1414 VenturesBoston, MA, USest. 20201414 VenturesBoston, MA, US · est. 2020

1414 Ventures: A venture capital firm investing in unique digital identity solutions for payments, cybersecurity, and privacy.

Investment Firm9

Okapi Venture CapitalLaguna Beach, CA, USest. 2005Okapi Venture CapitalLaguna Beach, CA, US · est. 2005

Okapi Venture Capital: Investing in early-stage IT and life science firms, providing capital and management support in the US.

Investment Firm8

Boldstart VenturesNew York City, NY, USest. 2010Boldstart VenturesNew York City, NY, US · est. 2010

Boldstart: A venture capital firm, collaborating with tech founders from inception, turning bold ideas into iconic companies.

Investment Firm25

Industry VenturesSan Francisco, CA, USest. 2000Industry VenturesSan Francisco, CA, US · est. 2000

Industry Ventures, L.L.C.: A global venture capital firm investing in tech start-ups at seed stage.

Investment Firm55

Recent news

The agentic AI era is forcing security and resilience into a single disciplineSiliconANGLE · 2026

Android is the best and worst thing about GooglebooksThe Verge · 2026

Okta moves inline to police what AI agents actually doSiliconAngle · 2026

Leadership at Okta

Emilie ChoiBoard Member

Todd McKinnonBoard Member

Pat GradyBoard Member

Becky SaegerBoard Member

Jeff EpsteinBoard Member

Mike StankeyBoard Member

Similar to Okta

SupabaseSingapore, SGAPIs, Databaseest. 2020SupabaseSingapore, SG · est. 2020

Supabase is an open-source Postgres development platform providing databases, authentication, APIs, and real-time subscriptions.

Series F · $916.1M350

Leadership at Herophilus

Kenneth KosikBoard Member

Similar to Herophilus

AxoSimNew Orleans, LA, USDrug Discoveryest. 2014AxoSimNew Orleans, LA, US · est. 2014

US-based AxoSim propels neuroscience advancements via our drug discovery platforms.

Series A · $10.5M46

NeuroX1Austin, TX, USDrug Discoveryest. 2021NeuroX1Austin, TX, US · est. 2021

NeuroX1: A computational startup designing novel compounds for neurodegenerative diseases using our proprietary platform.

System1 BiosciencesSan Francisco, CA, USDrugs, Neurotherapeuticsest. 2017System1 BiosciencesSan Francisco, CA, US · est. 2017

System1 Biosciences, a neurotherapeutics firm, uses advanced tech to discover drugs for complex neurological disorders.

Series A · $25M30

Quiver BioscienceCambridge, MA, USDrug Discovery, Genomicsest. 2013Quiver BioscienceCambridge, MA, US · est. 2013

Quiver Bioscience develops CNS drug discovery tools using human neuronal models and AI/ML.

Series B · $22.5M29

Leadership at System1 Biosciences

Sean EscolaCo-Founder

Saul KatoCo-Founder & CEO

Juliana HilliardR&D Lead

Similar to System1 Biosciences

Rosebud BiosciencesSan Carlos, CA, USDrug Discoveryest. 2020Rosebud BiosciencesSan Carlos, CA, US · est. 2020

Rosebud Biosciences: Pioneering drug discovery with organoids for rare genetic diseases.

HerophilusSan Francisco, CA, USDrug Discoveryest. 2017HerophilusSan Francisco, CA, US · est. 2017

Herophilus: Pioneering in neurotherapeutics discovery through advanced in vitro models.

NeuroX1Austin, TX, USDrug Discoveryest. 2021NeuroX1Austin, TX, US · est. 2021

NeuroX1: A computational startup designing novel compounds for neurodegenerative diseases using our proprietary platform.

Sinopia BiosciencesSan Diego, CA, USDrug Discoveryest. 2011Sinopia BiosciencesSan Diego, CA, US · est. 2011

Sinopia Biosciences, a San Diego-based company, is revolutionizing drug discovery with data-driven, high-throughput multi-omics and machine learning.

MojoAuthPalo Alto, CA, USest. 2021

MojoAuthPalo Alto, CA, US · est. 2021

MojoAuth sells a passwordless authentication and customer identity platform for consumer applications through one API.

OneLoginAliso Viejo, CA, USest. 2009OneLoginAliso Viejo, CA, US · est. 2009

OneLogin provides cloud-based identity and access management software that secures workforce, customer, and partner access to applications and devices.

Way SecuritySan Francisco, CA, USest. 2025Way SecuritySan Francisco, CA, US · est. 2025

AI platform that extends enterprise IAM controls across every app and identity.